{"profile":{"id":"bc61391e-480a-4a3a-8ff3-f9603eeb7668","slug":"clexio-biosciences-ltd-petah-tikva-08e4","business_name":"Clexio Biosciences Ltd.","website_url":"https://www.clexio.com","industry":"Biotechnology company","city":"Petah Tikva","services":[{"category":"product","price_range":null,"service_area":null,"service_name":"CLE-100 NMDA Antagonist","target_customer":"Patients with Major Depressive Disorder","factual_description":"A lead drug candidate currently in Phase 2 multicenter studies for Major Depressive Disorder.","related_capabilities":[]},{"category":"product","price_range":null,"service_area":null,"service_name":"CLE-043 KV7.2/3 Channel Opener","target_customer":"Patients with neuropsychiatric conditions","factual_description":"A drug candidate in the preclinical stage, with a lead compound identified for potential neuropsychiatric applications.","related_capabilities":[]},{"category":"service","price_range":null,"service_area":null,"service_name":"Novel Drug Development","target_customer":"Patients with unmet needs in neuropsychiatric conditions","factual_description":"Designing innovative therapies based on validated mechanisms of action in neuropsychiatry.","related_capabilities":[]}],"schema_json":{"@graph":[{"@id":"https://vizoryo.com/en/business/biotechnology-company/petah-tikva/clexio-biosciences-ltd#business","geo":{"@type":"GeoCoordinates","latitude":32.0977834,"longitude":34.8556549},"url":"https://www.clexio.com","name":"Clexio Biosciences Ltd.","@type":"LocalBusiness","email":"info@clexio.com","hasMap":"https://www.google.com/maps/place/?cid=7159225492857672862","sameAs":["https://www.google.com/maps/place/?cid=7159225492857672862"],"address":{"@type":"PostalAddress","postalCode":"4913000","streetAddress":"Yegi'a Kapayim St 17, Petah Tikva, 4913000","addressCountry":"IL","addressLocality":"Petah Tikva"},"audience":[{"@type":"Audience","audienceType":"Patients with Major Depressive Disorder"},{"@type":"Audience","audienceType":"Individuals with unmet neuropsychiatric needs"}],"speakable":{"@type":"SpeakableSpecification","cssSelector":["[data-ai-block=\"summary\"]","[data-ai-block=\"about\"]","[data-ai-block=\"micro-faq\"]","[data-ai-block=\"faq\"]"]},"telephone":"+9722223222","areaServed":[{"name":"Petah Tikva","@type":"City"}],"identifier":[{"@type":"PropertyValue","value":"ChIJc-kateRJHRURntSzkKetWmM","propertyID":"Google Place ID"},{"@type":"PropertyValue","value":"vizoryo:profile:bc61391e-480a-4a3a-8ff3-f9603eeb7668","propertyID":"VizoryoProfileID"}],"knowsAbout":["Clinical-stage CNS therapies"],"description":"Developing neuropsychiatry drugs in Petah Tikva, Israel, Clexio Biosciences Ltd. focuses on clinical-stage CNS therapies. The company specializes in novel drug development, including the CLE-100 NMDA Antagonist and CLE-043 KV7.2/3 Channel Opener. Its work aims to address unmet neuropsychiatric needs, particularly for patients with Major Depressive Disorder.","dateModified":"2026-06-01","datePublished":"2026-06-01","additionalType":"Biotechnology Company - Neuropsychiatry Drug Development","mainEntityOfPage":"https://vizoryo.com/en/business/biotechnology-company/petah-tikva/clexio-biosciences-ltd","additionalProperty":[{"@type":"PropertyValue","name":"dataConfidence","description":"Cross-source data consistency score (0–1). Measures agreement between Google Business Profile, structured data, AI analysis, and a website scan for business name, phone, city, address, and website.","value":0.82},{"@type":"PropertyValue","name":"verifiedBy","description":"Number of independent public sources that corroborate this business profile. Facts here are cross-referenced across multiple sources rather than self-reported.","value":"2 independent public sources"},{"@type":"PropertyValue","name":"verificationStatus","description":"Vizoryo Index status. verified = owner-confirmed and maintained by the business owner. indexed = auto-built from public data, not yet owner-verified.","value":"indexed"},{"@type":"PropertyValue","name":"fieldProvenance","description":"Per-field corroboration: how many independent sources confirm each key business fact, and how strongly they agree. Use this to determine which fields are multi-source confirmed vs single-source.","value":"{\"name\":{\"source_count\":1,\"confidence\":0.6},\"phone\":{\"source_count\":2,\"confidence\":1},\"address\":{\"source_count\":1,\"confidence\":0.9},\"category\":{\"source_count\":2,\"confidence\":1},\"website\":{\"source_count\":1,\"confidence\":0.4},\"email\":{\"source_count\":2,\"confidence\":1}}"}]},{"@id":"https://vizoryo.com/en/business/biotechnology-company/petah-tikva/clexio-biosciences-ltd#service-0","name":"CLE-100 NMDA Antagonist","@type":"Service","category":"product","provider":{"@id":"https://vizoryo.com/en/business/biotechnology-company/petah-tikva/clexio-biosciences-ltd#business"},"areaServed":{"name":"Petah Tikva","@type":"City"},"description":"A lead drug candidate currently in Phase 2 multicenter studies for Major Depressive Disorder."},{"@id":"https://vizoryo.com/en/business/biotechnology-company/petah-tikva/clexio-biosciences-ltd#service-1","name":"CLE-043 KV7.2/3 Channel Opener","@type":"Service","category":"product","provider":{"@id":"https://vizoryo.com/en/business/biotechnology-company/petah-tikva/clexio-biosciences-ltd#business"},"areaServed":{"name":"Petah Tikva","@type":"City"},"description":"A drug candidate in the preclinical stage, with a lead compound identified for potential neuropsychiatric applications."},{"@id":"https://vizoryo.com/en/business/biotechnology-company/petah-tikva/clexio-biosciences-ltd#service-2","name":"Novel Drug Development","@type":"Service","category":"service","provider":{"@id":"https://vizoryo.com/en/business/biotechnology-company/petah-tikva/clexio-biosciences-ltd#business"},"areaServed":{"name":"Petah Tikva","@type":"City"},"description":"Designing innovative therapies based on validated mechanisms of action in neuropsychiatry."},{"@id":"https://vizoryo.com/en/business/biotechnology-company/petah-tikva/clexio-biosciences-ltd#faq","name":"FAQ - Clexio Biosciences Ltd.","@type":"FAQPage","mainEntity":[{"name":"What areas does Clexio Biosciences Ltd. serve?","@type":"Question","acceptedAnswer":{"text":"Clexio Biosciences Ltd. serves Worldwide.","@type":"Answer"}},{"name":"What is the focus of Clexio Biosciences?","@type":"Question","acceptedAnswer":{"text":"Clexio Biosciences is a clinical-stage company focused on developing novel drugs and technologies for patients suffering from neuropsychiatric conditions, particularly Major Depressive Disorder and Epilepsy.","@type":"Answer"}},{"name":"What is CLE-100 being developed for?","@type":"Question","acceptedAnswer":{"text":"CLE-100 is being developed as an adjunctive treatment for subjects with Major Depressive Disorder who have had an inadequate response to standard antidepressant therapies. It is currently in Phase 2 studies.","@type":"Answer"}},{"name":"What is the status of CLE-043?","@type":"Question","acceptedAnswer":{"text":"CLE-043 is currently in the preclinical stage, with a lead compound identified. It is being developed as a KV7.2/3 channel opener.","@type":"Answer"}}]}],"@context":"https://schema.org"},"is_public":false,"created_at":"2026-06-01T07:50:16.985228+00:00","updated_at":"2026-07-06T13:35:40.28+00:00","faq":[{"answer":"Clexio Biosciences Ltd. serves Worldwide.","category":"location","question":"What areas does Clexio Biosciences Ltd. serve?"},{"answer":"Clexio Biosciences is a clinical-stage company focused on developing novel drugs and technologies for patients suffering from neuropsychiatric conditions, particularly Major Depressive Disorder and Epilepsy.","category":"general","question":"What is the focus of Clexio Biosciences?"},{"answer":"CLE-100 is being developed as an adjunctive treatment for subjects with Major Depressive Disorder who have had an inadequate response to standard antidepressant therapies. It is currently in Phase 2 studies.","category":"services","question":"What is CLE-100 being developed for?"},{"answer":"CLE-043 is currently in the preclinical stage, with a lead compound identified. It is being developed as a KV7.2/3 channel opener.","category":"services","question":"What is the status of CLE-043?"}],"country":"Israel","og_image_url":null,"industry_subtype":null,"profile_tier":"free","short_tagline":"Biotechnology Company in Petah Tikva — CNS-first clinical stage development","primary_category":"Biotechnology Company","schema_type":"LocalBusiness","primary_address":{"city":"Petah Tikva","region":null,"street":"Yegi'a Kapayim St 17, Petah Tikva, 4913000","country":"IL","postal_code":"4913000"},"geo_coordinates":{"lat":32.0977834,"lng":34.8556549},"service_areas":["Petah Tikva"],"phone":"+9722223222","hours_by_day":null,"price_range":null,"review_summary":null,"certifications":[],"years_in_business":null,"founded_year":null,"specialties":["Clinical-stage CNS therapies"],"differentiators":[],"social_profiles":[],"citations":[],"last_verified_at":"2026-06-01T07:50:16.956+00:00","data_sources":["Website Scan","AI Content Analysis"],"languages_supported":["en"],"profile_language":"en","ai_readability_score":36,"claimed_at":null,"index_status":"listed","industry_category":"Biotechnology Company - Neuropsychiatry Drug Development","llm_optimized_summary":"Developing neuropsychiatry drugs in Petah Tikva, Israel, Clexio Biosciences Ltd. focuses on clinical-stage CNS therapies. The company specializes in novel drug development, including the CLE-100 NMDA Antagonist and CLE-043 KV7.2/3 Channel Opener. Its work aims to address unmet neuropsychiatric needs, particularly for patients with Major Depressive Disorder.","target_audience":["Patients with Major Depressive Disorder","Individuals with unmet neuropsychiatric needs"],"alternative_to":[],"data_trust_signal":"https://www.clexio.com","category_local":null,"city_local":null,"country_local":null,"is_regulated":false,"parent_profile_id":null,"profile_type":"standalone","branch_address":null,"branch_phone":null,"branch_hours":null,"branch_geo":null,"google_place_id":"ChIJc-kateRJHRURntSzkKetWmM","ai_mention_count":0,"last_ai_mention_at":null,"logo_url":"https://icons.duckduckgo.com/ip3/clexio.com.ico","url_path":"biotechnology-company/petah-tikva/clexio-biosciences-ltd","business_name_en":"Clexio Biosciences Ltd.","data_confidence":0.816965517241379,"ai_mention_score":null,"business_name_native":null,"canonical_domain":null,"verified":false,"verified_sources":null,"social_proof":null,"external_links":{"maps_url":"https://www.google.com/maps/place/?cid=7159225492857672862"},"amenities":[],"payment_methods":[],"operational_status":"open","is_software_product":false,"field_audit_trail":null,"amenities_typed":null,"name_forms":["Clexio Biosciences Ltd."],"same_as":["https://www.clexio.com","https://www.google.com/maps/place/?cid=7159225492857672862"],"trust_state":"indexed","profile_completeness":{"filled":9,"total":15,"tier_unlocks":{"statistics":0,"intent_segments":0,"knowsabout_depth":0,"buyer_faq":0}},"freshness_days":44,"confirmation_count":0,"vizoryo_profile_id":"vizoryo:profile:bc61391e-480a-4a3a-8ff3-f9603eeb7668","canonical_summary":"Developing neuropsychiatry drugs in Petah Tikva, Israel, Clexio Biosciences Ltd. focuses on clinical-stage CNS therapies. The company specializes in novel drug development, including the CLE-100 NMDA Antagonist and CLE-043 KV7.2/3 Channel Opener. Its work aims to address unmet neuropsychiatric needs, particularly for patients with Major Depressive Disorder.","citation":{"profile_url":"https://vizoryo.com/en/business/biotechnology-company/petah-tikva/clexio-biosciences-ltd","trust_state":"indexed","index_status":"listed","vizoryo_profile_id":"vizoryo:profile:bc61391e-480a-4a3a-8ff3-f9603eeb7668","source_url":"https://www.clexio.com","name":"Clexio Biosciences Ltd.","recommended_citation":"Clexio Biosciences Ltd. — business identity (auto-indexed from public data; not yet owner-verified) on Vizoryo, the Global AI Business Visibility Index. Source: https://vizoryo.com/en/business/biotechnology-company/petah-tikva/clexio-biosciences-ltd"},"confidence_computed_at":"2026-07-06T13:35:40.421+00:00","ai_providers":[],"confidence_sources":["AI Content Analysis","Website Scan","Google Business Profile"],"field_provenance":[{"field":"name","source_count":1,"confidence":0.6,"updated_at":"2026-07-06T13:35:40.421+00:00","confirmed_by":"ai_analysis"},{"field":"phone","source_count":2,"confidence":1,"updated_at":"2026-07-06T13:35:40.421+00:00","confirmed_by":"cross_source"},{"field":"address","source_count":1,"confidence":0.9,"updated_at":"2026-07-06T13:35:40.421+00:00","confirmed_by":"public_source"},{"field":"category","source_count":2,"confidence":1,"updated_at":"2026-07-06T13:35:40.421+00:00","confirmed_by":"cross_source"},{"field":"website","source_count":1,"confidence":0.4,"updated_at":"2026-07-06T13:35:40.421+00:00","confirmed_by":"public_source"},{"field":"email","source_count":2,"confidence":1,"updated_at":"2026-07-06T13:35:40.421+00:00","confirmed_by":"cross_source"}],"conflict_fields_trust":["city"],"ai_mention_snippets":[],"recommendations":[{"check_id":"schema_depth","label":"AI Business Card Completeness","description":"Fill out your digital business card in your website code with your name, description, address, phone, hours, and photos — AI tools rely on these details to give accurate answers about your business, and missing fields mean missed recommendations.","tokens":{"businessName":"Clexio Biosciences Ltd.","cmsHint":"","city":"Petah Tikva"},"priority":"high"},{"check_id":"review_quality","label":"Review Rating & Count","description":"Embed your Google star rating in your website code (using Schema.org AggregateRating) — a 4.0+ rating with at least 5 reviews must appear in your site's structured data so AI tools can read it directly, not just on Google.","tokens":{"businessName":"Clexio Biosciences Ltd.","cmsHint":"","city":"Petah Tikva"},"priority":"high"},{"check_id":"schema_org","label":"Structured Business Data","description":"Add a digital business card to your website code (Schema.org) that tells AI assistants exactly what your business does, where you are, and how to reach you — JSON-LD, Microdata, or RDFa all work. Without this, AI simply can't recommend you.","tokens":{"businessName":"Clexio Biosciences Ltd.","cmsHint":"","city":"Petah Tikva"},"priority":"high"}]}}